ArticleRevista medica del Instituto Mexicano del Seguro Social2026
[Association between anthropometric clinical predictors and HOMA-IR].
Article in Revista medica del Instituto Mexicano del Seguro Social, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The HOMA-IR index is a test that identifies the early risk of developing type 2 diabetes mellitus (T2DM) by measuring insulin resistance (IR); however, these tests are not readily available in primary care settings. Predictors of IR, such as body mass index (BMI) and waist-to-hip ratio (WHR), are useful for the early detection of this risk. Objective: To associate anthropometric parameters with HOMA-IR, considering BMI. Material and methods: A cross-sectional, comparative study was conducted. Serum glucose and insulin concentrations were determined using non-probability convenience sampling and the difference of proportions formula to calculate the HOMA-IR index in 315 adults without diabetes. Anthropometric parameters and visceral fat were considered, and participants were divided into groups according to BMI: normal weight, overweight, and obesity. Differences between groups were determined by Kruskal-Wallis test and the risk of each variable through multiple logistic regression. Results: Of the 315 participants, 57% showed IR; most of them belonged to the overweight and obesity group. Serum insulin concentrations and IR differed significantly among the 3 BMI groups, primarily in the overweight and obesity groups. WHR is a good predictor of risk for IR. Conclusions: IR can be early detected by using validated indices such as HOMA-IR. At the primary care level, anthropometric parameters such as WHR can be used, as it has proven to be a better predictor of IR, phenomenon that occurs much earlier than hyperglycemia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.